APTV vs DMAC · P/E 41, rev $19.71B vs $157.4M cap
Aptiv PLC (APTV) versus DiaMedica Therapeutics Inc (DMAC) — a side-by-side from cached financials, not a winner call.
Aptiv PLC (APTV) is a auto parts company listed on US.
DiaMedica Therapeutics Inc (DMAC) is a biotechnology company listed on US.
Latest reported APTV revenue for 2024-12-31 was $19.71B. Net income was $275.0M. Revenue was down 1.7% from 2023-12-31 to 2024-12-31. APTV currently screens at market cap $14.52B and trailing P/E 40.8.
DMAC does not have a complete income-statement cache yet.
APTV currently screens at market cap $14.52B and trailing P/E 40.8. DMAC currently screens at market cap $157.4M.
Not investment advice. Open the APTV and DMAC stock pages for the full models.
Not investment advice.